HEALTH AND HAPPINESS (H&H) INTERNATIONAL HOLDINGS LIMITED

Health and Happiness (H&H) International Holdings Limited

1112

KYG4387E1070

Food Processing

Market Closed - Hong Kong S.E. Other stock markets 01:38:28 24/05/2024 pm IST			5-day change	1st Jan Change
10.28 ^HKD	-0.77%		-5.69%	-15.04%

17/05	Health and Happiness' Revenue Down 9% in Q1	MT
17/05	Health and Happiness (H&H) International Holdings Limited Reports Unaudited Consolidated Revenue Results for the Three Months Ended 31 March 2024	CI

Biostime International Holdings Limited Announces Resignation of Radek Sali as Executive Director, Effective 31 December 2016

December 15, 2016 at 05:26 am IST

The board of directors of Biostime International Holdings Limited announced that Mr. Radek Sali has tendered resignation to the Board as an executive director of the company, with effect from 31 December 2016 in order to devote more time to pursuing his personal and charitable ventures.

Latest news about Health and Happiness (H&H) International Holdings Limited

Health and Happiness' Revenue Down 9% in Q1	17/05	MT
Health and Happiness (H&H) International Holdings Limited Reports Unaudited Consolidated Revenue Results for the Three Months Ended 31 March 2024	17/05	CI
Health and Happiness (H&H) International Holdings Limited Approves Final Dividend for the Year Ended 31 December 2023	10/05	CI
Health and Happiness (H&H) International Holdings Limited Proposes Issue and Pricing of USD 120,200,000, 13.5% Senior Notes due 2026	08/04	CI
Jefferies Adjusts Health and Happiness International’s Price Target to HK$13 From HK$14, Keeps at Buy	28/03	MT
H&H’s Profit Down 5% in 2023	26/03	MT
Health and Happiness (H&H) International Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on July 10, 2024	26/03	CI
Health and Happiness (H&H) International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03	CI
Health And Happiness (H&H) International to Issue 500 Million Yuan of Bonds	21/03	MT
Health and Happiness (H&H) International Holdings Limited Announces Pricing of RMB 500,000,000 7.5% Guaranteed Bonds Due 2027	21/03	CI
H&H International Warns of Profit Decline	05/03	MT
Jefferies Adjusts Health and Happiness International’s Price Target to HK$14 From HK$13.10, Keeps at Buy	16/01	MT
Health and Happiness (H&H) International Holdings Limited Appoints Mrs. Mingshu Zhao Wiggins as Non-Executive Director, Effective from 1 January, 2024	29/12	CI
H&H International CEO Steps Down, Sets Up Rotational CEO Structure	20/11	MT
Health and Happiness (H&H) International Holdings Limited Announces Cessation of Camillo Pane as Chief Executive Officer	20/11	CI
Jefferies Adjusts Health and Happiness International’s Price Target to HK$13.10 From HK$13, Keeps at Buy	02/11	MT
H&H International Partially Buys Back Bonds Due in 2024	01/11	MT
H&H International Holdings' Q3 Revenue Jumps 2%	01/11	MT
Health and Happiness (H&H) International Holdings Limited Reports Unaudited Consolidated Revenue Results for the Three Months and Nine Months Ended 30 September 2023	01/11	CI
H&H International Holdings Repurchases $4.1 Million in 2026 Bonds	06/23/06	MT
Jefferies Adjusts Health and Happiness International’s Price Target to HK$13 From HK$13.40, Keeps at Buy	24/23/24	MT
Transcript : Health and Happiness (H&H) International Holdings Limited, H1 2023 Earnings Call, Aug 23, 2023	23/23/23
Health and Happiness (H&H) International Holdings Limited Declares Interim Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 13 October 2022	22/23/22	CI
Health and Happiness (H&H) International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	22/23/22	CI
H&H International Holdings' First-Half Revenue Grows in Double Digits; Shares Rise 5%	18/23/18	MT

Chart Health and Happiness (H&H) International Holdings Limited

Duration

Period

Chart Health and Happiness (H&H) International Holdings Limited

More charts

Company Profile

Health and Happiness (H&H) International Holdings Limited, formerly Biostime International Holdings Ltd., is an investment holding company principally engaged in the manufacture and sale of premium pediatric nutritional. The Company operates through five business segments. The Infant Formulas segment is engaged in the production of infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. The Adult Nutrition and Care Products segment is engaged in the production of vitamins, health supplements, skin care and sports nutrition products for adults. The Probiotic Supplements segment is engaged in the production of probiotic supplements. The Dried Baby Food and Nutrition Supplements segment is engaged in the production of dried baby food products made from natural foods, as well as microencapsulated milk calcium chewable tablets. The Baby Care Products segment is engaged in the production of baby care products.

Sector

Food Processing

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company